Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,250 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | AGRANT◷◆ | 8,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,250 | — | — | +4.0% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 20,000 | $45.00 | $900K | -16.0% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 20,000 | $17.96 | $359.2K | +19.0% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,559 | $42.53 | $66.3K | -1.5% | Open the original filing on SEC.gov |
| Apr 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 5,226 | $41.62 | $217.5K | -4.7% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 7,215 | $41.93 | $302.5K | -6.0% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 37,500 | $41.07 | $1.5M | -23.9% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 7,500 | $15.46 | $116K | +5.0% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 20,000 | $17.96 | $359.2K | +15.5% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $19.08 | $190.8K | +8.4% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | AGRANT◷ | 14,000 | — | — | +13.3% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 10,000 | $30.00 | $300K | -8.7% | Open the original filing on SEC.gov |
| Apr 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $15.46 | $154.6K | +9.5% | Open the original filing on SEC.gov |